drugset / Trial / NCT00010127

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

NCT00010127

Treatment

Summary

RATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill prostate tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have metastatic prostate cancer.

Timeline

Start
2000-11
Primary completion
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous dendritic cells Cell therapy Other

Indications